Testicular cancer has been a model for a curable malignancy. The existence of an array of potential new therapies is the result of a prodigious effort in the researching and defining of the molecular components of the cancer phenotype and the subsequent rational design of agents to target candidate pathways. A better understanding of the molecular biology of cancer may also aid in guiding the most appropriate use of existing therapies, such as conventional chemotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hoc.2011.03.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!